本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Candel Therapeutics, Inc.

5.42
-0.5550-9.29%
盘前5.620.2000+3.69%04:29 EDT
成交量:124.60万
成交额:708.58万
市值:2.98亿
市盈率:-10.38
高:6.27
开:5.94
低:5.39
收:5.98
52周最高:14.60
52周最低:3.79
股本:5,489.51万
流通股本:4,547.85万
量比:1.15
换手率:2.74%
股息:- -
股息率:- -
每股收益(TTM):-0.5221
每股收益(LYR):-1.7420
净资产收益率:-55.18%
总资产收益率:-33.39%
市净率:3.30
市盈率(LYR):-3.11

数据加载中...

2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities